Ayuda
Ir al contenido

Dialnet


SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

    1. [1] Hospital Universitario Virgen de las Nieves

      Hospital Universitario Virgen de las Nieves

      Granada, España

    2. [2] Hospital Reina Sofía

      Hospital Reina Sofía

      Tudela, España

    3. [3] Gobierno de Navarra

      Gobierno de Navarra

      Pamplona, España

    4. [4] University of Manchester

      University of Manchester

      Reino Unido

    5. [5] Hospital Universitario Virgen del Rocío

      Hospital Universitario Virgen del Rocío

      Sevilla, España

    6. [6] Hospital Universitario Central de Asturias

      Hospital Universitario Central de Asturias

      Oviedo, España

    7. [7] Hospital Universitario Marqués de Valdecilla

      Hospital Universitario Marqués de Valdecilla

      Santander, España

    8. [8] Hospital Universitario 12 de Octubre

      Hospital Universitario 12 de Octubre

      Madrid, España

    9. [9] Instituto de Investigaciones Biomédicas de Málaga
    10. [10] Hospital Universitario Vall Hebron
  • Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 21, Nº. 1 (January 2019), 2019, págs. 55-63
  • Idioma: inglés
  • Texto completo no disponible (Saber más ...)
  • Resumen
    • NENs are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise across all sites, stages and grades. Although improved diagnostic techniques have led to earlier detection and stage migration, the improved prognosis documented over time for advanced gastrointestinal and pancreatic neuroendocrine tumors also reflect improvements in therapy. The aim of this guideline is to update practical recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification and therapeutic options are briefly discussed, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, and treatment algorithms are provided.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno